Glycopyrronium Bromide and Neostigmine Metilsulfate 0.5mg / 2.5mg per ml Solution for Injection
*Company:
ADVANZ PharmaStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 23 February 2022
File name
Glycopyrronium Bromide and Neostigmine Metilsulfate 0.5mg 2.5mg.pdf
Reasons for updating
- Change to section 6.1 - List of excipients
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
A National Type IB variation under category A.3 for change in name of an excipient from Neostigmine metilsulphate to Neostigmine metilsulfate and Sulphonic acid to Sulfonic acid.
Updated on 30 December 2021
File name
Glycopyrronium Bromide and Neostigmine Metilsulfate_SPC_IE.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 30 December 2021
File name
Glycopyrronium Bromide and Neostigmine Metilsulfate_PIL_IE.pdf
Reasons for updating
- New PIL for new product